Shangyi Fu

925 total citations
32 papers, 672 citations indexed

About

Shangyi Fu is a scholar working on Molecular Biology, Oncology and Ophthalmology. According to data from OpenAlex, Shangyi Fu has authored 32 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Ophthalmology. Recurrent topics in Shangyi Fu's work include Retinal Development and Disorders (10 papers), Retinal Diseases and Treatments (4 papers) and Nigella sativa pharmacological applications (4 papers). Shangyi Fu is often cited by papers focused on Retinal Development and Disorders (10 papers), Retinal Diseases and Treatments (4 papers) and Nigella sativa pharmacological applications (4 papers). Shangyi Fu collaborates with scholars based in United States, China and Iran. Shangyi Fu's co-authors include Junjiang Fu, Md. Asaduzzaman Khan, Mousumi Tania, Jingliang Cheng, Saber İmani, Chunli Wei, Xiuli Xiao, Luquan Yang, Jiewen Fu and Xianqin Zhang and has published in prestigious journals such as Human Molecular Genetics, Molecules and Investigative Ophthalmology & Visual Science.

In The Last Decade

Shangyi Fu

30 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shangyi Fu United States 14 367 179 143 105 78 32 672
Tuomas Paimela Finland 10 352 1.0× 187 1.0× 55 0.4× 39 0.4× 34 0.4× 14 642
Jacek Bigda Poland 12 270 0.7× 27 0.2× 64 0.4× 71 0.7× 124 1.6× 38 569
Ana Neves‐Costa Portugal 13 418 1.1× 56 0.3× 48 0.3× 8 0.1× 118 1.5× 19 741
Joshua D. Bosman United States 6 438 1.2× 104 0.6× 38 0.3× 16 0.2× 41 0.5× 7 559
Sabnam Parbin India 15 592 1.6× 36 0.2× 159 1.1× 14 0.1× 108 1.4× 26 758
Himani Sharma India 9 388 1.1× 15 0.1× 77 0.5× 13 0.1× 76 1.0× 11 577
Deshun Gong China 11 445 1.2× 68 0.4× 49 0.3× 6 0.1× 40 0.5× 16 639
Yong Zeng China 13 849 2.3× 23 0.1× 266 1.9× 4 0.0× 67 0.9× 30 1.2k
Andreas Dumont Germany 4 247 0.7× 13 0.1× 126 0.9× 19 0.2× 62 0.8× 5 476
Huiqiong He China 12 254 0.7× 15 0.1× 92 0.6× 29 0.3× 45 0.6× 16 519

Countries citing papers authored by Shangyi Fu

Since Specialization
Citations

This map shows the geographic impact of Shangyi Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shangyi Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shangyi Fu more than expected).

Fields of papers citing papers by Shangyi Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shangyi Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shangyi Fu. The network helps show where Shangyi Fu may publish in the future.

Co-authorship network of co-authors of Shangyi Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Shangyi Fu. A scholar is included among the top collaborators of Shangyi Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shangyi Fu. Shangyi Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fu, Shangyi, et al.. (2023). Two years of a pilot virtual melanoma education program for adolescents in Texas: Assessing knowledge gaps and demographic disparities. Baylor University Medical Center Proceedings. 37(2). 361–365.
3.
Fu, Shangyi, Jiewen Fu, Khosrow Jadidi, et al.. (2023). Novel pathogenic CERKL variant in Iranian familial with inherited retinal dystrophies: genotype–phenotype correlation. 3 Biotech. 13(6). 166–166. 2 indexed citations
4.
Fu, Shangyi, et al.. (2023). Mental health trends among medical students. Baylor University Medical Center Proceedings. 36(3). 408–410. 12 indexed citations
5.
Cheng, Jingliang, Ting Li, Jiewen Fu, et al.. (2023). Novel, pathogenic insertion variant of GSDME associates with autosomal dominant hearing loss in a large Chinese pedigree. Journal of Cellular and Molecular Medicine. 28(1). e18004–e18004. 4 indexed citations
6.
7.
Shen, Shiyi, et al.. (2022). HSPA6 and its role in cancers and other diseases. Molecular Biology Reports. 49(11). 10565–10577. 20 indexed citations
8.
Fu, Shangyi, et al.. (2022). Skin, hair, and nail supplements advertised on Instagram. Baylor University Medical Center Proceedings. 36(1). 38–40. 4 indexed citations
9.
Rui, Qi, Shangyi Fu, Qingnan Liang, et al.. (2021). A novel stop codon mutation of TSPAN12 gene in Chinese patients with familial exudative vitreoretinopathy. Ophthalmic Genetics. 43(2). 210–217. 1 indexed citations
10.
Cheng, Jingliang, Shangyi Fu, Jiewen Fu, et al.. (2021). Prostate adenocarcinoma and COVID‐19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS‐CoV‐2. Journal of Cellular and Molecular Medicine. 25(8). 4157–4165. 25 indexed citations
11.
Li, Dabing, Xiaoyan Liu, Lianmei Zhang, et al.. (2021). COVID-19 disease and malignant cancers: The impact for the furin gene expression in susceptibility to SARS-CoV-2. International Journal of Biological Sciences. 17(14). 3954–3967. 30 indexed citations
12.
Fu, Jiewen, Shangyi Fu, Jingliang Cheng, et al.. (2021). Technical note: multi-alleles at the DYS385ab locus with high frequency in a Han Chinese population from southwestern China. International Journal of Legal Medicine. 135(5). 1737–1741. 8 indexed citations
13.
Zhang, Tao, Xuesen Cheng, Austin D. Igelman, et al.. (2021). Noncoding mutation in RPGRIP1 contributes to inherited retinal degenerations.. PubMed. 27. 95–106. 6 indexed citations
14.
Cheng, Jingliang, Jiewen Fu, Qi Zhou, et al.. (2019). A novel splicing mutation in the PRPH2 gene causes autosomal dominant retinitis pigmentosa in a Chinese pedigree. Journal of Cellular and Molecular Medicine. 23(5). 3776–3780. 18 indexed citations
15.
Fu, Jiewen, Lu Ma, Jingliang Cheng, et al.. (2018). A novel, homozygous nonsense variant of the CDHR1 gene in a Chinese family causes autosomal recessive retinal dystrophy by NGS‐based genetic diagnosis. Journal of Cellular and Molecular Medicine. 22(11). 5662–5669. 18 indexed citations
16.
İmani, Saber, et al.. (2018). Molecular genetics characterization and homology modeling of the CHM gene mutation: A study on its association with choroideremia. Mutation Research/Reviews in Mutation Research. 775. 39–50. 26 indexed citations
17.
Wei, Chunli, Lisha Yang, Jingliang Cheng, et al.. (2018). A novel homozygous variant of GPR98 causes usher syndrome type IIC in a consanguineous Chinese family by next generation sequencing. BMC Medical Genetics. 19(1). 99–99. 14 indexed citations
18.
19.
İmani, Saber, et al.. (2018). In silico data analyses of the hotspot mutations of CHM gene in choroideremia disease. Data in Brief. 18. 1217–1223. 4 indexed citations
20.
İmani, Saber, Jingliang Cheng, Marzieh Dehghan Shasaltaneh, et al.. (2017). Genetic identification and molecular modeling characterization reveal a novelPROM1mutation in Stargardt4-like macular dystrophy. Oncotarget. 9(1). 122–141. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tuomas Paimela Breakdown of academic impact, for papers by Jacek Bigda Breakdown of academic impact, for papers by Ana Neves‐Costa Breakdown of academic impact, for papers by Joshua D. Bosman Breakdown of academic impact, for papers by Sabnam Parbin Breakdown of academic impact, for papers by Himani Sharma Breakdown of academic impact, for papers by Deshun Gong Breakdown of academic impact, for papers by Yong Zeng Breakdown of academic impact, for papers by Andreas Dumont Breakdown of academic impact, for papers by Huiqiong He
Rankless by CCL
2026